First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent
Condition: Healthy Interventions: Drug: RVP-001; Drug: Placebo Sponsors: Reveal Pharmaceuticals Inc.; National Cancer Institute (NCI); Quotient Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2022 Category: Research Source Type: clinical trials
An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma
Conditions: Solid Tumor; Lymphoma Interventions: Drug: Manganese Chloride; Radiation: Radiotherapy; Drug: Chemo-immunotherapy Sponsor: Chinese PLA General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2021 Category: Research Source Type: clinical trials